MXPA01003240A - Mamaglobina, una proteina secretada del cancer mamario especifica de mama. - Google Patents

Mamaglobina, una proteina secretada del cancer mamario especifica de mama.

Info

Publication number
MXPA01003240A
MXPA01003240A MXPA01003240A MXPA01003240A MXPA01003240A MX PA01003240 A MXPA01003240 A MX PA01003240A MX PA01003240 A MXPA01003240 A MX PA01003240A MX PA01003240 A MXPA01003240 A MX PA01003240A MX PA01003240 A MXPA01003240 A MX PA01003240A
Authority
MX
Mexico
Prior art keywords
mamaglobin
mom
methods
breast cancer
mamaglobina
Prior art date
Application number
MXPA01003240A
Other languages
English (en)
Spanish (es)
Inventor
Mark A Watson
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of MXPA01003240A publication Critical patent/MXPA01003240A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MXPA01003240A 1998-09-29 1999-09-29 Mamaglobina, una proteina secretada del cancer mamario especifica de mama. MXPA01003240A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/162,622 US6566072B1 (en) 1995-05-31 1998-09-29 Mammaglobin, a secreted mammary-specific breast cancer protein
PCT/US1999/022616 WO2000018783A1 (en) 1998-09-29 1999-09-29 Mammaglobin, a secreted mammary-specific breast cancer protein

Publications (1)

Publication Number Publication Date
MXPA01003240A true MXPA01003240A (es) 2003-06-24

Family

ID=22586430

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01003240A MXPA01003240A (es) 1998-09-29 1999-09-29 Mamaglobina, una proteina secretada del cancer mamario especifica de mama.

Country Status (15)

Country Link
US (1) US6566072B1 (cg-RX-API-DMAC7.html)
EP (1) EP1117673A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002525098A (cg-RX-API-DMAC7.html)
KR (1) KR20010075418A (cg-RX-API-DMAC7.html)
CN (1) CN1328567A (cg-RX-API-DMAC7.html)
BR (1) BR9914161A (cg-RX-API-DMAC7.html)
CA (1) CA2343980C (cg-RX-API-DMAC7.html)
CZ (1) CZ20011025A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0104408A3 (cg-RX-API-DMAC7.html)
IL (1) IL142079A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01003240A (cg-RX-API-DMAC7.html)
NO (1) NO20011394L (cg-RX-API-DMAC7.html)
PL (1) PL347021A1 (cg-RX-API-DMAC7.html)
TR (1) TR200101702T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000018783A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
EP1517913B9 (en) * 1999-10-07 2007-08-29 Corixa Corporation A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
CN100577815C (zh) * 2003-05-01 2010-01-06 维里德克斯有限责任公司 手术中的淋巴结检测
US7662580B2 (en) * 2005-11-10 2010-02-16 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
CN105548364B (zh) * 2015-12-10 2018-11-02 北京理工大学 热障涂层结合强度的高阶非线性参数表征方法
EP3699595A1 (en) * 2019-02-22 2020-08-26 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Use of bmmf1 rep protein as a biomarker for breast cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5573916A (en) 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
WO1998021331A1 (en) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins

Also Published As

Publication number Publication date
TR200101702T2 (tr) 2001-12-21
PL347021A1 (en) 2002-03-11
US6566072B1 (en) 2003-05-20
EP1117673A1 (en) 2001-07-25
IL142079A0 (en) 2002-03-10
EP1117673A4 (en) 2004-08-04
WO2000018783A1 (en) 2000-04-06
NO20011394D0 (no) 2001-03-19
KR20010075418A (ko) 2001-08-09
JP2002525098A (ja) 2002-08-13
HUP0104408A2 (hu) 2002-03-28
CZ20011025A3 (cs) 2001-09-12
CA2343980C (en) 2012-06-26
CN1328567A (zh) 2001-12-26
NO20011394L (no) 2001-05-22
WO2000018783A9 (en) 2000-09-21
BR9914161A (pt) 2001-06-26
WO2000018783B1 (en) 2000-05-11
CA2343980A1 (en) 2000-04-06
HUP0104408A3 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
BR9812472A (pt) Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
PE20050712A1 (es) Anticuerpos rg1
UY28289A1 (es) Anticuerpos recombinantes y fragmentos que reconocen el gangliosido n-glicolil gm3 y su uso para diasnostico y tratamiento de tumores
NO20032674L (no) Isoindolin-1-on-glukokinase-aktivatorer
ATE242326T1 (de) Rekombinante humanisierte antikörper gegen lewis y
AR077759A2 (es) Anticuerpos bloqueadores de cripto composiciones que los comprenden y usos y metodos que los utilizan
ES2142790T3 (es) Epitopos antigenicos presentes sobre iga unida a la membrana pero no secretada.
DE69839273D1 (de) Krebs immuntherapie mit semi-allogenen zellen
ATE404669T1 (de) In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
PT1290160E (pt) Polipeptideos pellino humanos
MX9606369A (es) Supresion del crecimiento de celulas tumorales mediante el ectodominio de syndecan-1.
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
AR031641A1 (es) Combinacion inmunoterapeutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina
MX9700800A (es) Células portadoras de receptores de señuelo cd4 y moléculas y métodos relacionados.
AR023599A1 (es) Sobreexpresion de una secuencia de adn que codifica para una 5-fosfato de 1-desoxi-d-xilulosa-reductoisomerasa en plantas
BR0012446A (pt) Proteìna da rede de leitura alternativa do receptory de células t e uso da mesma
UY27060A1 (es) Composición vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
UY26127A1 (es) Antígeno asociado con tumores
AR023380A1 (es) Compuestos para la terapia y el diagnostico de cancer de pulmon y metodos de uso de los mismos
SU1129921A1 (ru) Штамм дизэмбриогенетической опухоли кишечника, используемый для изучения патогенеза и лечения злокачественного роста